Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Clinical trial NCT02587520 · COMPLETED
Trial details
- NCT number
- NCT02587520
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-22
- Primary completion
- 2017-02-21
- Enrollment
- 1363
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.